The medication used in the EP Protocol, Enclomiphene, maintains or improves the Testosterone: DHT ratio, so it shouldn't negatively impact prostate function.
While we do not treat BPH, there is a patent for using enclomiphene (aka trans-clomiphene) for the treatment of BPH from the original pharmaceutical company that developed it: